Gut mucosal and adipose tissues as health targets of the immunomodulatory mechanisms of probiotics
Authors:
- Tolulope Joshua AshaoluTATolulope Joshua Ashaolu
- Samuel Fernández-ToméSFSamuel Fernández-Tomé
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 112, 764-779
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (CD17/00014)
This publication has 191 references indexed in Scilit:
- Richness of human gut microbiome correlates with metabolic markersNature, 2013
- RETRACTED ARTICLE: Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithiiInternational Journal of Obesity, 2011
- Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled StudyAmerican Journal of Gastroenterology, 2010
- Toward defining the autoimmune microbiome for type 1 diabetesThe ISME Journal, 2010
- Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trialEuropean Journal of Clinical Nutrition, 2010
- The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative ColitisClinical Gastroenterology and Hepatology, 2009
- Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cellsJournal of Hepatology, 2008
- Host-bacteria interaction in inflammatory bowel diseaseBritish Medical Bulletin, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- Human gut microbes associated with obesityNature, 2006